Life Insurance documents, forms and updates.

  • Applying for cover?

    PDSs

    PDS updates

    New Zurich Wealth Protection management fees, effective 1 March 2018

    This information updates the information set out on page 46 of the Zurich Wealth Protection PDS, dated 15 May 2017.

    From 1 March 2018, the management fees will be indexed in line with the consumer price index. The new management fees are as follows:

    Premium frequency Management fee payable Annual equivalent
    Monthly $9.44 $113.28
    Quarterly $28.29 $113.16
    Half-yearly $47.18 $94.36
    Yearly $94.35 $94.35

    The management fees above apply for new policies until 28 February 2019. The management fee increases each year on the policy anniversary in line with the consumer price index.

    New Zurich Sumo management fees, effective 1 March 2018

    This information updates the information set out on page 21 of the Zurich Sumo PDS, dated 15 May 2017.

    From 1 March 2018, the management fees will be indexed in line with the consumer price index. The new management fees are as follows:

    Premium frequency Management fee payable Annual equivalent
    Monthly $25.75 $309.00
    Quarterly $77.25 $309.00
    Half-yearly $154.50 $309.00
    Yearly $309.00 $309.00

    The management fee will be adjusted each year on 1 March by the greater of 3% and the consumer price index, and will be effective from the policy commencement date or policy anniversary on or following 1 March.

    New Zurich FutureWise management fees, effective 1 March 2018

    This information updates the information set out on page 54 of the Zurich FutureWise PDS, dated 1 October 2016.

    The amounts set out in the PDS were current up to 28 February 2017 and subsequently updated on the Zurich website on 1 March 2017.

    Policy fee

    A policy fee per insured person per application is also payable each year and is shown on your policy schedule. If more than one Zurich FutureWise policy is issued as a result of a single application for an insured person, only one policy fee is payable.

    As at 1 March 2018, the policy fee is $100.38 per annum if the premium is paid annually or $8.37 per month if the premium is paid monthly, plus any stamp duty that is applicable. The policy fee will be adjusted each year on 1 March by the consumer price index, and will be effective from the cover start date or cover anniversary on or following 1 March.

    If there is no 1 March PDS issued in any year, we will advise the updated policy fees on our website, zurich.com.au

    Zurich Wealth Protection - Financial planning advice benefit in the Zurich Insurance-only Superannuation Plan, effective 18 December 2017

    The Zurich Wealth Protection Financial planning advice reimbursement benefit will continue to be a ‘standard built-in benefit’ of the product and be payable in the circumstances described in the PDS.  For applications for a Zurich Wealth Protection policy to be issued into the Zurich Insurance-only Superannuation Plan of the Aon Master Trust made from 18 December 2017, the benefit will not form part of the main policy contract terms.  Instead it will be provided under a separate insurance certificate, made by Zurich directly to the Life Insured.

    Insurance Certificate from Zurich Australia Limited

    Financial planning advice reimbursement benefit for
    Zurich Wealth Protection members of the
    Zurich Insurance-only Superannuation Plan

    Zurich Australia Limited (Zurich) undertakes to provide an additional payment to help reimburse the cost of financial planning advice which you or your dependants may take about how to best use a benefit to be paid under a policy held for you by the trustee of the Zurich Insurance-only Superannuation Plan, a division of the Aon Master Trust (Fund).  Zurich will provide the Financial planning Advice Reimbursement Benefit (Benefit) in recognition of your contributions to the Fund, which the Fund trustee will use to pay the premiums for the insured benefits from that Fund that are financed by your policy.  However, the Benefit is not provided by your policy in the Fund, but as an additional payment under this Certificate, that is provided directly to you or your dependants by Zurich.

    Zurich will require a copy of the Statement of Advice and invoice from a licensed financial planner as proof of the expense before the Benefit can be paid.  This reimbursement is only paid once in respect of each policy held by the Fund trustee for you, is payable directly to the person who incurred the expense and may be split between them where more than one of your dependants takes advice and seeks reimbursement.  The maximum total reimbursement amount was described in the product disclosure statement for your policy.  The Benefit is separate from and replaces of any benefit of this type described in your policy document.

    The Zurich Wealth Protection Product Disclosure Statement with issue date of 15 May 2017 (20 April 2017 Preparation Date) is accordingly updated as follows:

    1. The heading ‘In built policy provisions’ is replaced with ‘Additional in-built product features’ on pages 6, 7 & 10
    2. The following words are added to the explanation of the ‘Financial planning advice’ reimbursement benefit at the foot of page 17. 

    This benefit is provided under a separate policy certificate provided by Zurich, and not as part of the Zurich Protection Plus policy contract terms.

    Financial Ombudsman Service (FOS) - new contact details, effective 11 December 2017

    The contact number for the Financial Ombudsman Service (FOS) has changed.  The following PDSs are updated to reflect that change:

    • Zurich Wealth Protection, with issue date of 15 May 2017
    • Zurich Active, with issue date of 15 May 2017
    • Zurich Sumo, with issue date of 15 May 2017
    • Zurich FutureWise, with issue date of 1 October 2016

    The Complaints resolution section on the inside back cover of the Zurich Wealth Protection, Zurich Active and Zurich Sumo PDSs and on page 60 of the Zurich FutureWise PDS, is updated to include the new free call number, as set out below:

    Complaints resolution

    If you have a complaint about any product described in this PDS, you should contact Zurich Customer Care on 131 551. We will aim to acknowledge any complaint within 5 days and to resolve your complaint within 45 days. If you are not satisfied with the response you receive from us, or we fail to resolve the complaint within 45 days, you can raise the matter with the Financial Ombudsman Service (FOS). FOS is an independent body designed to help you resolve complaints relating to your Zurich product, as well as complaints relating to financial or investment advice and sales of financial or investment products.

    You can contact FOS at GPO Box 3, Melbourne VIC 3001.

    The telephone number is: 1800 367 287 (or 1800 FOS AUS) and the email address is: info@fos.org.au.

    If you wish to complain about a policy which is held in super, you will need to contact the superannuation fund trustee.

    Life Insurance Code of Practice - minimum standard trauma definitions, effective 1 July 2017

    As a member of the Financial Services Council of Australia (the FSC), Zurich is bound by the Life Insurance Code of Practice (the Code) with effect from 1 July 2017. The Code outlines the standards that we are committed to in providing life insurance services to you. The Code can be found at www.fsc.org.au.

    This information updates the information set out in the Zurich Wealth Protection, Zurich Active and Zurich Sumo PDSs, all dated 15 May 2017 and the Zurich FutureWise PDS dated 1 October 2016, but only in relation to the eligible products outlined below.

    Announcing our commitment to minimum standard trauma definitions for policies issued from 1 July 2017

    As part of our commitment to the Code, Zurich is pleased to be able to provide policyholders with even greater certainty about the strength of their trauma insurance definitions.

    In order to create a minimum standard across the market for the most commonly claimed trauma conditions, the Code now sets out minimum standard trauma definitions for the following three conditions:

    • cancer – excluding specified early stage cancers
    • heart attack – with evidence of severe heart muscle damage
    • stroke – in the brain resulting in specified permanent impairment.

    At claim time, where there is a minimum standard trauma definition in the Code for your trauma condition, we will assess your claim against:

    • the applicable definition in our PDS and
    • the corresponding minimum standard medical definition in the Code that is current at the time of the insured event

    so that you get the better of the two definitions.

    The definitions for these conditions have been incorporated into the Code, and can be found on the FSC website www.fsc.org.au.  The definitions will be regularly reviewed and updated as necessary to ensure that any required tests, treatments and grading systems are aligned with up-to-date medical practice in Australia.  Any updated definitions will automatically apply once they are adopted into the Code.

    Eligibility

    Minimum standard trauma definitions apply to the first $2million of any trauma cover issued under Zurich Protection Plus and Zurich Child Cover (Wealth Protection), Zurich Child Cover (Active), Zurich Life Insurance (Sumo) and Zurich Trauma Insurance (FutureWise) on or after 1 July 2017.  They specifically do not apply to health events cover issued under Zurich Active, which provides tiered benefits for health events and is structured differently to trauma cover.  Minimum standard trauma definitions also do not apply to any trauma cover issued as part of an income protection policy.

    Zurich FutureWise - new definitions, effective 15 May 2017

    This information updates the information set out in the Zurich FutureWise PDS, dated 1 October 2016.  The relevant section of the PDS is the Glossary, which begins on page 64.

    Zurich has made a number of changes to policy definitions to ensure that they continue to reflect modern procedures and terminology.  These definitions affect life and trauma cover, including optional trauma benefits under Disability Income Insurance.

    Effective from 15 May 2017:

    • the following Trauma definitions are updated:
      • cancer
      • idiopathic pulmonary arterial hypertension (previously primary pulmonary hypertension)
    • the definition of terminal illness has been updated.

    The new definitions which apply from 15 May 2017 are set out below:

    cancer

    The presence of one or more malignant tumours, including lymphoma (including Hodgkin’s and non Hodgkin’s disease), leukaemia, multiple myeloma and malignant bone marrow disorders, that are characterised by the uncontrolled growth and spread of malignant cells and the invasion and destruction of normal tissue.

    The following cancers are excluded:

    • tumours which are histologically described as premalignant or show the malignant changes of carcinoma in situ (including cervical dysplasia CIN III and lower). Carcinoma in situ of the breast is covered if it results directly in the removal of the entire breast (including nipple sparing mastectomy). This procedure must be performed specifically to arrest the spread of malignancy and be considered the appropriate and necessary treatment
    • melanomas which are less than stage T1bN0M0
    • all hyperkeratoses and basal cell carcinomas, and squamous cell or intra-epidermal carcinomas of skin unless there is spread to other organs
    • chronic lymphocytic leukaemia less than Rai stage 1, and
    • prostatic cancers which are TNM Classification T1 or less and have a Gleason score of 6 or less.

    Prostatic cancer which is TNM classification T1 or less and which has a Gleason score of 6 or less is covered if it results in the entire removal of the prostate. This procedure must be performed specifically to arrest the spread of malignancy and be considered the appropriate and necessary treatment by a medical practitioner.

    idiopathic pulmonary arterial hypertension (previously primary pulmonary hypertension)
    Idiopathic pulmonary arterial hypertension characterised by enlargement of the right ventricle as a result of high pulmonary artery pressure. It must have resulted in significant cardiac and respiratory impairment leading to impairment equivalent to at least Class III of the New York Heart Association functional classification system.

    terminal illness
    If the policy is not issued to the trustee of a superannuation fund: any condition caused by illness or injury, where despite all reasonable medical treatment, the life insured is expected to live for no more than 24 months as confirmed and certified* by:

    • a specialist registered medical practitioner treating the condition with supporting evidence of the condition, possible medical treatment and the prognosis, and
    • if required by us, a specialist registered medical practitioner approved by us who is an expert in the condition.

    If the policy is issued to a trustee of a superannuation fund: any condition caused by illness or injury, where despite all reasonable medical treatment, the life insured is expected to live for no more than 24 months as confirmed and certified* by:

    • a specialist registered medical practitioner treating the condition with supporting evidence of the condition, possible medical treatment and the prognosis, and
    • a registered medical practitioner approved by us.

    * The period of life expectancy, certified by each medical practitioner, must not have ended.

    Zurich Income Replacement - new Trauma definitions, effective 1 September 2016 and 15 May 2017

    This information updates the information set out in the Zurich Income Replacement PDS, dated 21 December 2015.  The relevant section of the PDS is the Definitions for specified trauma conditions section, which begins on page 35.

    Zurich has made a number of changes to policy definitions to ensure that they continue to reflect modern diagnostic procedures, treatments and terminology.

    Effective from 1 September 2016, the following Trauma definitions are updated:

    • out of hospital cardiac arrest and
    • severe rheumatoid arthritis with permanent daily life impact (previously severe rheumatoid arthritis).

    Effective from 15 May 2017, the following Trauma definitions are updated:

    • carcinoma in situ
    • deafness
    • dementia (including Alzheimer’s disease)
    • early stage melanoma
    • heart attack
    • idiopathic pulmonary arterial hypertension (replaces primary pulmonary hypertension)
    • loss of hearing in one ear
    • malignant cancer and
    • Parkinson’s disease.

    The definitions which apply from the above effective dates are all set out in the Zurich Wealth Protection PDS dated 15 May 2017

  • Existing customers

    Current PDSs

    Forms

    Policy updates (improvements passed back to you)

    When we make changes to our products, we pass back as many improvements as we can to existing customers for new conditions occurring after the effective date of the change.  Details of our most recent enhancements are set out here.  Not all of the improvements will apply to your policy – you should refer to your policy schedule and for more detail about the cover you hold, and contact your adviser if you need more information.

    If you have Optional Protection Benefits attached to a Zurich Superannuation Plan (ZSP), then the changes which apply to your cover are the same as those outlined for Wealth Protection for Superannuation Term Life Plus, Superannuation Income Protector and Superannuation Income Replacement (as applicable) – however prior to 2011, the date when each change is effective corresponds to the relevant ZSP PDS issue date and not the Wealth Protection PDS issue date.

    Policy updates for Wealth Protection customers

    The above summary document sets out all the changes made to Wealth Protection over time which have been passed back to existing customers under the guarantee of upgrade.

    The information below explains the most recent changes on 15 May 2017.


    Terms for all of the following improvements can be found in the relevant section of the Zurich Wealth Protection PDS dated 15 May 2017. Where the improvement is in relation to a defined term, please refer to the definitions section.

    Any claims for conditions which first occurs after the effective date indicated, will be assessed against the original terms set out in your policy, as well as the new terms indicated. Zurich takes this ‘dual approach’ to ensure we provide you with the best possible level of protection, as you can qualify under either approach.

    All Wealth Protection policies
    The following feature is updated with effect from 15 May 2017:

    • The Premium holiday feature is now more flexible, allowing any number of months of premium holiday (up to 12) to be selected.

    Death cover
    The following features are updated with effect from 15 May 2017:

    • The in-built Future insurability business benefit will now allow an increase in Death cover based on an increase in size of a business loan.
    • The definition of terminal illness has been improved so that it is now an advance payment of the Death benefit if the life insured is diagnosed as terminally ill and expected to live for no more than 24 months (certain medical certification requirements apply). The definition previously restricted payments to life expectancy of less than 12 months.

    Extended trauma
    Some Extended trauma condition definitions have been updated with two effective dates:

    • The following trauma conditions have updated definitions effective from 1 September 2016:
      • out of hospital cardiac arrest and
      • rheumatoid arthritis.
    • The following trauma conditions have updated definitions effective from 15 May 2017:
      • carcinoma in situ
      • deafness
      • dementia (including Alzheimer’s disease)
      • early stage melanoma
      • heart attack
      • idiopathic pulmonary arterial hypertension (replaces primary pulmonary hypertension)
      • loss of hearing in one ear
      • malignant cancer and
      • Parkinson’s disease.

    Basic trauma
    The following trauma conditions have updated definitions with effect from 15 May 2017:

    • heart attack and
    • malignant cancer.

    Income Replacement
    The Trauma option (available under the Comprehensive level of cover) and the Trauma benefit (Premier level of cover) pay a benefit based on the Extended trauma covered conditions.  We have updated some Extended trauma conditions with two effective dates, as follows:

    • The following Extended trauma conditions have updated definitions effective from 1 September 2016:
      • out of hospital cardiac arrest and
      • rheumatoid arthritis.
    • The following Extended trauma conditions have updated definitions effective from 15 May 2017:
      • carcinoma in situ
      • deafness
      • dementia (including Alzheimer’s disease)
      • early stage melanoma
      • heart attack
      • idiopathic pulmonary arterial hypertension (replaces primary pulmonary hypertension)
      • loss of hearing in one ear
      • malignant cancer and
      • Parkinson’s disease.

    Income Protector
    The following features are updated with effect from 15 May 2017:

    • Qualifying for a Total disability or Partial disability benefit is now less onerous. The life insured must be totally disabled for at least five consecutive days during the waiting period in order to qualify, where this qualification period previously extended to the entire waiting period.
    • Agreed value benefits which are reduced at claim time (because they exceed 75% of income at application) will now be assessed on an indemnity basis as a minimum benefit threshold, so that an agreed value policy will always pay at least as much as an indemnity policy for total disability.
    • The Funeral benefit will now pay a lump sum of 4 times the insured monthly benefit in the event of death during a claim.
    • A waiting period of 1 or 2 years (taken in conjunction with salary continuance cover via and employer) can be reduced without medical underwriting to 1 year or 90 days if the life insured leaves that employer and no longer has the cover.
    • (If the Trauma option is selected) We have updated our definitions for two of the trauma conditions which apply to the Trauma option, to ensure that they reflect the most up to date medical practices. The conditions which have updated definitions are:
      • heart attack and
      • malignant cancer.

    Superannuation Income Protector
    The following features are updated with effect from 15 May 2017:

    • Qualifying for a Total disability or Partial disability benefit is now less onerous. The life insured must be totally disabled for at least five consecutive days during the waiting period in order to qualify, where this qualification period previously extended to the entire waiting period.
    • The Funeral benefit will now pay a lump sum of 4 times the insured monthly benefit in the event of death during a claim.
    • A waiting period of 1 or 2 years (taken in conjunction with salary continuance cover via and employer) can be reduced without medical underwriting to 1 year or 90 days if the life insured leaves that employer and no longer has the cover.

    Policy updates for Active customers

     Zurich Active - Summary of changes
    Issue date: 30 April 2018

    The above summary document sets out all the changes made to Active over time which have been passed back to existing customers under the guarantee of upgrade.

    The information below explains the most recent change on 30 April 2018.


    Health events

    Effective from 30 April 2018, Zurich has:

    • added a number of new Health events to the policy
    • moved a number of Health events to a higher benefit category, increasing the benefit payable for those Health events
    • made a number of changes to existing Health event definitions aimed at making the events more objectively measurable and ensuring that they continue to reflect modern diagnostic procedures and treatments.

    Terms for all of the following Health event improvements can be found in the relevant section of the Zurich Active PDS dated 30 April 2018. As these improvements apply to the Health event defined terms, please refer to the ‘Health events & benefit categories’ and ‘Definitions’ sections of the PDS.

    Upgrades only apply to new conditions occurring after the effective date indicated. Any claims for such conditions will be assessed against the original terms set out in your policy, as well as the new terms indicated. Zurich takes this ‘dual approach’ to ensure we provide you with the best possible level of protection, as you can qualify under either approach.

    The following additional Health events have been added to the policy, effective 30 April 2018:

    • advanced diabetes
    • bacterial meningitis
    • diabetes (type 1)
    • early stage chronic lymphocytic leukaemia
    • encephalitis
    • out of hospital cardiac arrest
    • severe rheumatoid arthritis with permanent daily life impact

    The following Health events have moved to a higher benefit category, effective 30 April 2018:

    • coma (from benefit category E to C)
    • diagnosis of motor neurone disease (from benefit category B to A)
    • paraplegia (from benefit category B to A)
    • severe osteoporosis before age 50 (from benefit category E to C)
    • total cystectomy requiring a urinary conduit (from benefit category C to B)
    •  total mastectomy for carcinoma in situ of the breast (from benefit category D to C)

    The following Health events have updated definitions, effective 30 April 2018:

    • cancer
    • chronic lung disease
    • coma
    • complete loss of hearing
    • complete loss of hearing in one ear
    • confirmed diagnosis of myelodysplastic syndrome or any myeloproliferative diseases
    • gastrointestinal disease
    •  heart attack
    • intensive care unit (ICU) / hospital admission
    • lymphoma
    • malignant brain tumour
    • pancreas transplant / waiting list
    • permanent and irrecoverable loss of sight
    • permanent vegetative state (now permanent unresponsive state)
    • prostate cancer requiring radiotherapy, brachytherapy or radical prostatectomy
    • severe crohn’s disease
    • severe loss of binaural hearing
    • severe peripheral vascular disease resulting in amputation of the leg or entire foot
    • stroke
    • total mastectomy

    In addition to the above list, the definitions under the headings ‘Brain and nerves’ and ‘Musculoskeletal system’ have been extensively updated to make them more objectively measurable and ensuring that they continue to reflect modern diagnostic procedures and treatments.

    Policy updates for Sumo customers

     Zurich Sumo - Summary of changes
    Issue date: 15 May 2017

    The above summary document sets out all the changes made to Sumo over time which have been passed back to existing customers.

    The information below explains the most recent changes on 1 October 2016 and 15 May 2017.


    Zurich has made a number of changes to policy definitions to ensure that they continue to reflect modern diagnostic procedures and treatments.

    The new terms are automatically passed on to Sumo policy holders for insured events which occur on or after the date of the change.  Any claims lodged for these conditions, which first occurred after the date indicated, will be assessed against the original definition set out in your policy, as well as the new definition. Zurich takes this ‘dual approach’ to ensure we provide you with the best possible level of protection, as you can qualify under either definition.

    Effective from 1 October 2016, the definition of heart attack was updated. The definition which applies from 1 October 2016 to 14 May 2017 can be found in the definitions section of the 1 October 2016 Zurich Sumo PDS.

    Effective from 15 May 2017:

    • the following Trauma definitions are updated:
      • cancer
      • early stage melanoma
      • heart attack
      • idiopathic pulmonary arterial hypertension (previously primary pulmonary hypertension)
      • loss of hearing
      • partial loss of hearing and
      • stroke.
    • the definition of terminal illness has been improved so that it is now an advance payment of the Death benefit if the life insured is diagnosed as terminally ill and expected to live for no more than 24 months (certain medical certification requirements apply). The definition previously restricted payments to life expectancy of less than 12 months.

    The definitions which apply from 15 May 2017 can be found in the definitions section of the 15 May 2017 Zurich Sumo PDS.

    Policy updates for FutureWise customers

    The above summary document sets out all the changes made to FutureWise over time which have been passed back to existing customers.

    The information below explains the most recent changes on 1 October 2016 and 15 May 2017.


    Zurich has made a number of changes to policy definitions to ensure that they continue to reflect modern procedures and terminology.

    The new terms are automatically passed on to FutureWise policy holders for insured events which occur on or after the date of the change.  Any claims lodged for these conditions, which first occurred after the date indicated, will be assessed against the original definition set out in your policy, as well as the new definition. Zurich takes this ‘dual approach’ to ensure we provide the best possible level of protection, as the life insured can qualify under either definition.

    Effective from 1 October 2016, the definition of heart attack was updated. The definition which applies can be found in the definitions section of the 1 October 2016 Zurich FutureWise PDS.

    Effective from 15 May 2017:

    • the following Trauma definitions are updated:
      • cancer and
      • idiopathic pulmonary arterial hypertension (previously primary pulmonary hypertension).
    • the definition of terminal illness has been improved so that it is now an advance payment of the Death benefit if the life insured is diagnosed as terminally ill and expected to live for no more than 24 months (certain medical certification requirements apply). The definition previously restricted payments to life expectancy of less than 12 months.

    The new definitions which apply from 15 May 2017 are set out below:

    cancer
    The presence of one or more malignant tumours, including lymphoma (including Hodgkin’s and non Hodgkin’s disease), leukaemia, multiple myeloma and malignant bone marrow disorders, that are characterised by the uncontrolled growth and spread of malignant cells and the invasion and destruction of normal tissue.

    The following cancers are excluded:

    • tumours which are histologically described as premalignant or show the malignant changes of carcinoma in situ (including cervical dysplasia CIN III and lower). Carcinoma in situ of the breast is covered if it results directly in the removal of the entire breast (including nipple sparing mastectomy). This procedure must be performed specifically to arrest the spread of malignancy and be considered the appropriate and necessary treatment
    • melanomas which are less than stage T1bN0M0
    • all hyperkeratoses and basal cell carcinomas, and squamous cell or intra-epidermal carcinomas of skin unless there is spread to other organs
    • chronic lymphocytic leukaemia less than Rai stage 1, and
    • prostatic cancers which are TNM Classification T1 or less and have a Gleason score of 6 or less.

    Prostatic cancer which is TNM classification T1 or less and which has a Gleason score of 6 or less is covered if it results in the entire removal of the prostate. This procedure must be performed specifically to arrest the spread of malignancy and be considered the appropriate and necessary treatment by a medical practitioner.

    idiopathic pulmonary arterial hypertension (previously primary pulmonary hypertension)
    Idiopathic pulmonary arterial hypertension characterised by enlargement of the right ventricle as a result of high pulmonary artery pressure. It must have resulted in significant cardiac and respiratory impairment leading to impairment equivalent to at least Class III of the New York Heart Association functional classification system.

    terminal illness
    If the policy is not issued to the trustee of a superannuation fund: any condition caused by illness or injury, where despite all reasonable medical treatment, the life insured is expected to live for no more than 24 months as confirmed and certified* by:

    • a specialist registered medical practitioner treating the condition with supporting evidence of the condition, possible medical treatment and the prognosis, and
    • if required by us, a specialist registered medical practitioner approved by us who is an expert in the condition.

    If the policy is issued to a trustee of a superannuation fund: any condition caused by illness or injury, where despite all reasonable medical treatment, the life insured is expected to live for no more than 24 months as confirmed and certified* by:

    • a specialist registered medical practitioner treating the condition with supporting evidence of the condition, possible medical treatment and the prognosis, and
    • a registered medical practitioner approved by us.

    * The period of life expectancy, certified by each medical practitioner, must not have ended.

    Policy updates for Super Protector customers

    The above summary document sets out all the changes made to Super Protector over time which have been passed back to existing customers.

    The information below explains the most recent change on 15 May 2017.


    Zurich has recently completed a review of policy definitions to ensure that they continue to reflect modern procedures and terminology.

    The new terms are automatically passed on to Super Protector policy holders for insured events which occur on or after the date of the change.  Any claims lodged for these conditions, which first occurred after the date indicated, will be assessed against the original definition set out in your policy, as well as the new definition. Zurich takes this ‘dual approach’ to ensure we provide the best possible level of protection, as the life insured can qualify under either definition.

    Effective from 15 May 2017, the definition of terminal illness has been improved so that it is now an advance payment of the Death benefit if the life insured is diagnosed as terminally ill and expected to live for no more than 24 months (certain medical certification requirements apply). The definition previously restricted payments to life expectancy of less than 12 months.

    The new definition which applies from 15 May 2017 is set out below:

    terminal illness means any condition caused by illness or injury, where despite all reasonable medical treatment, the life insured is expected to live for no more than 24 months as confirmed and certified* by:

    • a specialist registered medical practitioner treating the condition with supporting evidence of the condition, possible medical treatment and the prognosis, and
    • a registered medical practitioner approved by us.

    * The period of life expectancy, certified by each medical practitioner, must not have ended.

    Policy updates for Superannuation Insurance customers (Macquarie Superannuation Plan)

    The above summary document sets out the changes made to insurance sold with the Macquarie Superannuation Plan between 1999 and 2008 (excluding Super Protector and FutureWise), which have been passed back to existing customers.

    PDS archives

    Zurich Wealth Protection

     2017 Zurich Wealth Protection and Zurich Insurance-only Superannuation Plan Product Disclosure Statement
    Zurich Wealth Protection PDS issue date: 15 May 2017; Zurich Insurance-only Superannuation Plan PDS issue date: 18 December 2017

    Zurich Active

    Zurich FutureWise

     2016 Zurich FutureWise and Zurich Insurance-only Superannuation Plan PDS
    Zurich FutureWise PDS issue date: 1 October 2016; Zurich Insurance-only Superannuation Plan PDS issue date: 18 December 2017

    Zurich Superannuation Plan – optional protection benefits

    Prior to 1 March 2011, the Optional Protection Benefits offered under the Zurich Superannuation Plan (ZSP) were outlined in the ZSP PDS.